Please try another search
WATERTOWN, Mass., April 25, 2024 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of small molecule medicines using...
CAMBRIDGE, Mass., April 25, 2024 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining...
CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--Bicycle Therapeutics plc (NASDAQ: BCYC), a biopharmaceutical company pioneering a new and differentiated class of therapeutics based on its...
ImmunoGen Inc. (NASDAQ:SASY) and Takeda. ImmunoGen, Inc. Price ImmunoGen, Inc. Price | ImmunoGen, Inc. QuoteZacks RankImmunoGen currently carries a Zacks Rank #3 (Hold). You can see the complete...
Moving ahead with Factor-D in rare diseasesThanks to its strong balance sheet following the out-licensing deal with Janssen in May 2015, Achillion Pharmaceuticals Inc (O:ACHN) appears to be well...
Oryzon’s core expertise lies in developing small molecule inhibitors for epigenetic targets. The company has advanced its lead compound ORY-1001 to a Phase I/IIa trial in acute leukaemia...
Instrument Type
Region
Sector
Industry
Date
Category
Provider